Localized Epidermal Cysts as a Radiation Recall Phenomenon in a Melanoma Patient Treated with Radiotherapy and the BRAF Inhibitor Vemurafenib

BRAF inhibitors are broadly used for metastatic melanoma with BRAF mutations. Their use results in various cutaneous side effects, such as the development of keratoacanthomas and squamous cell carcinomas. We report a patient with metastatic melanoma treated with vemurafenib who developed dozens of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Houriet, Carine, Klass, Natalie D., Beltraminelli, Helmut, Borradori, Luca, Oberholzer, Patrick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: September, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209266/
https://www.ncbi.nlm.nih.gov/pubmed/25408648
http://dx.doi.org/10.1159/000367708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209266/
https://www.ncbi.nlm.nih.gov/pubmed/25408648
http://dx.doi.org/10.1159/000367708

Ejemplares similares